Biogen Downgraded On Pipeline Setbacks And Leqembi Sales Slowdown
Jefferies downgraded Biogen Inc (NASDAQ:BIIB), citing the company’s tough setup. Leqembi (lecanemab) sales growth remains ...
Biogen expects steady growth for Alzheimer's drug Leqembi in near term
Biogen expects growth of its keenly watched Alzheimer's disease drug, Leqembi, to see a "linear trend" in the United States ...
New Alzheimer’s drugs are available, but can you get them in Florida?
The federal Food & Drug Administration has approved two new Alzheimer’s medications that can offer people more time to live ...
Grasping for hope: The heartbreaking journey through Alzheimer’s drug trials
For spouses who care for a partner with Alzheimer’s disease, every day brings a different battle and a new challenge. Every ...
Does Medicare cover Leqembi?
Medicare Part B covers Leqembi for people with early Alzheimer's or mild cognitive impairment. Learn more about Leqembi and Medicare coverage here.
The Register-Herald2d
Rockefeller Neuroscience Institute expands access to groundbreaking Alzheimer’s treatment
The drugs aducanumab (Aduhelm), lecanemab (Leqembi), and donanemab (Kisunla) work to reduce the buildup of plaques in the ...
A health system that is sick: America must treat its chronic disease crisis
The nomination of Robert F. Kennedy Jr. as secretary of health and human services has sparked considerable outrage, focused ...
Grasping for hope: The optimism and despair of an Alzheimer’s caregiver
For spouses who care for a partner with Alzheimer’s disease, every day brings a different battle and a new challenge. Every ...
Yahoo Finance10d
"LEQEMBI®" (Lecanemab) Approved for the Treatment of Early Alzheimer's Disease in Mexico
monoclonal antibody "LEQEMBI ®" (lecanemab) for the treatment of early Alzheimer's disease (AD)*. Eisai logo (PRNewsfoto/Eisai Inc.) ...
Eisai And Biogen : Mexico Approves LEQEMBI For Early Alzheimer's Disease Treatment
Eisai Co., Ltd. (ESALF.PK) and Biogen Inc. (BIIB) announced that the Federal Commission for the Protection Against Sanitary Risk ...
The Victoria Advocate11d
"LEQEMBI®" (Lecanemab) Approved for the Treatment of Early Alzheimer's Disease in Mexico
TOKYO and CAMBRIDGE, Mass., Dec. 4, 2024 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate ...